softie
Posts:
1,070
From:
Croydon, Surrey
Registered:
07-Feb-2004
|
|
Re: new CF drug
Posted:
15-Dec-2006 19:42
|
|
While this new drug is being taken, people with the right mutation will produce enough working CFTR (the protein coded for by the CF gene) to have a reduction in symptoms. As soon as they stop taking it then they will start to deteriorate at the normal rate. Also, while it may reduce symptoms enough that the lungs can reverse some damage, much of the damage will be irreversible.
I assume the Trust isn't in on this because doctors in this country would be able to find too few patients with this mutation to make it worth the effort of setting up trials. The American company will be able to make money out of their large Jewish population and the worldwide population of peple with that particular mutation, and it is worth it for doctors in Israel as they have such a very large population with that mutation.
As far as helping the rest of us... Well, probably not. Each mutation is different and needs treating differently, so what is learnt about that mutation will be of little relevance to what works for other genes. This doesn't apply to gene therapy, which aims to add a completely working copy of the gene, and should work whatever pre-existing copies of the gene there are.
Richard.
|
|